Glenmark Pharmaceuticals has informed that it enclosed a media release titled ‘Glenmark Pharmaceuticals receives ANDA approval for Calcipotriene and Betamethasone Dipropionate Foam, 0.005% 0.064%’.
The above information is a part of company’s filings submitted to BSE.